BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8563886)

  • 21. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis.
    Matsumoto T; Nakamura S; Jo Y; Yao T; Iida M
    Am J Gastroenterol; 2003 Aug; 98(8):1827-33. PubMed ID: 12907339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysplasia and cancer in ulcerative colitis: a soluble problem?
    Riddell RH
    Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.
    Rutter MD; Saunders BP; Wilkinson KH; Rumbles S; Schofield G; Kamm MA; Williams CB; Price AB; Talbot IC; Forbes A
    Gastroenterology; 2006 Apr; 130(4):1030-8. PubMed ID: 16618396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DNA ploidy and dysplasia in ulcerative colitis--interim analysis of a prospective study].
    Porschen R; Molsberger G; Reis C; Borchard F; Reis HE; Eckardt VF; Purrmann J; Hengels KJ; Strohmeyer G
    Z Gastroenterol; 1992 Dec; 30(12):857-62. PubMed ID: 1481552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of dysplasia in ulcerative colitis.
    Vatn MH; Elgjo K; Bergan A
    Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer surveillance colonoscopy in ulcerative colitis: sense or nonsense?
    Schapiro M
    Schweiz Med Wochenschr Suppl; 1996; 79():5S-8S. PubMed ID: 8701261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
    Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
    Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk of colorectal cancer in ulcerative colitis--monitoring strategies and identification of risk patients].
    Porschen R; Strohmeyer G
    Z Gastroenterol; 1992 Sep; 30(9):585-93. PubMed ID: 1449007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.
    Hata K; Watanabe T; Kazama S; Suzuki K; Shinozaki M; Yokoyama T; Matsuda K; Muto T; Nagawa H
    Br J Cancer; 2003 Oct; 89(7):1232-6. PubMed ID: 14520452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma?
    Bruewer M; Krieglstein CF; Utech M; Bode M; Rijcken E; Anthoni C; Laukoetter MG; Schuermann G; Senninger N
    World J Surg; 2003 May; 27(5):611-5. PubMed ID: 12715233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The malignant side of chronic inflammatory bowel disease].
    West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Most dysplasia in ulcerative colitis is visible at colonoscopy.
    Rutter MD; Saunders BP; Wilkinson KH; Kamm MA; Williams CB; Forbes A
    Gastrointest Endosc; 2004 Sep; 60(3):334-9. PubMed ID: 15332019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences.
    van den Broek FJ; Stokkers PC; Reitsma JB; Boltjes RP; Ponsioen CY; Fockens P; Dekker E
    Am J Gastroenterol; 2014 May; 109(5):715-22. PubMed ID: 21427710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirements of a cancer screening program to be scientifically credible.
    Riddell RH
    J Gastroenterol; 1995 Nov; 30 Suppl 8():43-4. PubMed ID: 8563887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.